Augmenting Ankle Plantarflexor Function in Cerebral Palsy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Augmenting Ankle Plantarflexor Function in Cerebral Palsy — Stella

Home/Cerebral Palsy/

View on ClinicalTrials.gov

Recruiting

Back to Cerebral Palsy trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Gillette Children's Specialty Healthcare, Minneapolis, Minnesota

Key details

Phase

Early testing

Sponsor

Northern Arizona University

Collaborators

Gillette Children's Specialty Healthcare, University of Washington

Enrollment target

~36 participants

Started

February 2023

Primary completion

September 2026

Age range

8 Years – 21 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.